JP2023538871A5 - - Google Patents
Info
- Publication number
- JP2023538871A5 JP2023538871A5 JP2023510345A JP2023510345A JP2023538871A5 JP 2023538871 A5 JP2023538871 A5 JP 2023538871A5 JP 2023510345 A JP2023510345 A JP 2023510345A JP 2023510345 A JP2023510345 A JP 2023510345A JP 2023538871 A5 JP2023538871 A5 JP 2023538871A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA202070526 | 2020-08-12 | ||
| DKPA202070526 | 2020-08-12 | ||
| PCT/EP2021/072251 WO2022034062A1 (en) | 2020-08-12 | 2021-08-10 | Exendin-4 peptide analogues |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023538871A JP2023538871A (ja) | 2023-09-12 |
| JPWO2022034062A5 JPWO2022034062A5 (https=) | 2024-08-19 |
| JP2023538871A5 true JP2023538871A5 (https=) | 2024-08-19 |
Family
ID=80246995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023510345A Pending JP2023538871A (ja) | 2020-08-12 | 2021-08-10 | エキセンジン－４ペプチド類似体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230303640A1 (https=) |
| EP (1) | EP4196495A1 (https=) |
| JP (1) | JP2023538871A (https=) |
| CN (1) | CN116390938A (https=) |
| AU (1) | AU2021324066A1 (https=) |
| BR (1) | BR112023002608A2 (https=) |
| CA (1) | CA3190959A1 (https=) |
| WO (1) | WO2022034062A1 (https=) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4356108A (en) | 1979-12-20 | 1982-10-26 | The Mead Corporation | Encapsulation process |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| JP4394279B2 (ja) | 1998-03-09 | 2010-01-06 | ジーランド ファーマ アクティーゼルスカブ | 酵素加水分解に対する傾向が減少した薬理学的に活性なペプチド複合体 |
| US6528486B1 (en) * | 1999-07-12 | 2003-03-04 | Zealand Pharma A/S | Peptide agonists of GLP-1 activity |
| EP1076066A1 (en) * | 1999-07-12 | 2001-02-14 | Zealand Pharmaceuticals A/S | Peptides for lowering blood glucose levels |
| EP1525219B1 (en) * | 2002-07-04 | 2009-05-27 | Zealand Pharma A/S | Glp-1 and methods for treating diabetes |
| EP1919947B1 (en) | 2005-08-26 | 2013-02-27 | AbbVie Inc. | Therapeutically active alpha-msh analogues |
| JP5241849B2 (ja) * | 2007-11-16 | 2013-07-17 | ノボ・ノルデイスク・エー／エス | インスリン及びインスリン分泌性ペプチドを含む薬学的組成物 |
| JP2014521594A (ja) * | 2011-05-25 | 2014-08-28 | アミリン・ファーマシューティカルズ，リミテッド・ライアビリティ・カンパニー | 長持続期間デュアルホルモンコンジュゲート |
| US9217023B2 (en) | 2012-10-19 | 2015-12-22 | Txp Pharma Gmbh | Alpha- and gamma-MSH analogues |
| HK1211232A1 (en) * | 2012-12-21 | 2016-05-20 | Sanofi | Exendin-4 derivatives as dual glp1/gip or trigonal glp1/gip/glucagon agonists |
| EP3838285A1 (en) | 2014-04-22 | 2021-06-23 | TXP Pharma GmbH | Peptide analogues with branched amino acid probe(s) |
| AR110300A1 (es) * | 2016-12-02 | 2019-03-13 | Sanofi Sa | Compuestos como agonistas peptídicos trigonales de los receptores de glp1 / glucagón / gip |
-
2021
- 2021-08-10 WO PCT/EP2021/072251 patent/WO2022034062A1/en not_active Ceased
- 2021-08-10 AU AU2021324066A patent/AU2021324066A1/en active Pending
- 2021-08-10 EP EP21766122.2A patent/EP4196495A1/en active Pending
- 2021-08-10 CA CA3190959A patent/CA3190959A1/en active Pending
- 2021-08-10 US US18/020,813 patent/US20230303640A1/en active Pending
- 2021-08-10 JP JP2023510345A patent/JP2023538871A/ja active Pending
- 2021-08-10 BR BR112023002608A patent/BR112023002608A2/pt unknown
- 2021-08-10 CN CN202180069840.1A patent/CN116390938A/zh active Pending